Bioneer Corp. is the one and only provider of a “total solution for molecular diagnostics” in Korea. The company has independently developed the equipment, kits and reagents for molecular diagnostic tests using around 200 patented technologies. They have secured a competitive advantage in terms of pricing and distribution, with the capability to manufacture everything they need, from raw materials to state-of-the-art equipment, on their own. Based on a turnkey lab operation, they are exporting to more than 90 countries around the world.

Using the molecular diagnostic kits from Bioneer Corp., it is possible to obtain accurate results using trace amounts of samples. The company has developed diagnostic kits for a wide range of applications, including COVID-19 testing as well as AIDS, hepatitis, tuberculosis and STD testing, organ transplantation screening, cancer screening and hereditary disease screening. They currently have more than 40 different molecular diagnostic kits in their product line.

ExiStation™ is an automated molecular diagnostic system from Bioneer Corp. for extraction, amplification and analysis of nucleic acids from samples. It boasts excellent performance and convenience, and it is also compact in size. With a product lineup of diverse nucleic extraction equipment and real-time PCR equipment, Bioneer is capable of supplying an optimized system for each customer according to their needs in relation to test volume and types.

The molecular diagnostic kits developed by Bioneer Corp. are of world-class standards. The COVID-19 diagnostic kit, in particular, has been evaluated to exhibit 100% sensitivity by the Foundation for Innovative New Diagnostics (FIND). The company also became the world’s first to receive the Emergency Use Authorization (EUA) by the World Health Organization (WHO) for a multi-diagnostic kit for the Zika virus, and it is the sole manufacturer in Asia to obtain the CE marking for in vitro diagnostic medical devices (IVDs) for AIDS, hepatitis B and hepatitis C (List A).
*FIND: A non-profit international organization that evaluates diagnostic products by carrying out in-house clinical experiments. They are known for the transparency and reliability of their evaluation results, attested by the fact that the health departments of countries around the world as well as WHO and the US Centers for Disease Control and Prevention refer to their reports when purchasing diagnostic products.